Trends in the incidence and mortality of intracerebral hemorrhage, and the associated risk factors, in Denmark from 2004 to 2017

被引:7
作者
Pedersen, Tine Glavind Bulow [1 ]
Vinter, Nicklas [1 ,2 ,3 ]
Schmidt, Morten [2 ,4 ,5 ]
Frost, Lars [1 ,2 ]
Cordsen, Pia [3 ]
Andersen, Grethe [2 ,6 ]
Johnsen, Soren Paaske [3 ]
机构
[1] Silkeborg Reg Hosp, Univ Res Clin Innovat Patient Pathways, Diagnost Ctr, Silkeborg, Denmark
[2] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
[3] Aalborg Univ, Danish Ctr Clin Hlth Serv Res, Dept Clin Med, Aalborg, Denmark
[4] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark
[5] Reg Hosp West Jutland, Dept Cardiol, Herning, Denmark
[6] Aarhus Univ Hosp, Dept Neurol, Aarhus, Denmark
关键词
epidemiology; intracerebral hemorrhage; risk factors; ORAL ANTICOAGULANTS; NATIONWIDE TRENDS; CASE-FATALITY; STROKE; POPULATION; WARFARIN; CARE; UK; PRESCRIPTION; OXFORDSHIRE;
D O I
10.1111/ene.15110
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose The distribution of the major modifiable risk factors for intracerebral hemorrhage (ICH) changes rapidly. These changes call for contemporary data from large-scale population-based studies. The aim of the present study was to examine trends in incidence, risk factors, and mortality in ICH patients from 2004 to 2017. Methods In a population-based cohort study, we calculated age- and sex-standardized incidence rates (SIRs), incidence rates (IRs) stratified by age and sex per 100,000 person-years, and trends in risk profiles. We estimated absolute mortality risk, and the Cox proportional hazards regression multivariable-adjusted hazard ratios for 30-day and 1-year mortality. Results We included 16,902 patients (53% men; median age 75 years) from 2004 to 2017. The SIR of ICH decreased from 33 (95% confidence interval [CI] 32-34) in 2004/2005 to 28 (95% CI 27-29) in 2016/2017. Among patients aged >= 70 years, the IR decreased from 137 (95% CI 130-144) in 2004/2005 to 112 (95% CI 106-117) in 2016/2017. The IR in patients aged <70 years was unchanged. From 2004 to 2017, the proportion of patients with hypertension increased from 49% to 66%, the use of oral anticoagulants increased from 7% to 18%, and the use of platelet inhibitors decreased from 40% to 28%. The adjusted hazard ratio for 30-day mortality in 2016/2017 was 0.94 (95% CI 0.89-1.01) and 1-year mortality was 0.98 (95% CI 0.93-1.04) compared with 2004/2005. Conclusion The incidence of spontaneous ICH decreased from 2004 to 2017, with no clear trend in mortality. The risk profile of ICH patients changed substantially, with increasing proportions of hypertension and anticoagulant treatment. Given the high mortality rate of ICH, further advances in prevention and treatment are urgently needed.
引用
收藏
页码:168 / 177
页数:10
相关论文
共 41 条
  • [1] Sixteen-year nationwide trends in antithrombotic drug use in Denmark and its correlation with landmark studies
    Adelborg, Kasper
    Grove, Erik Lerkevang
    Sundboll, Jens
    Laursen, Maja
    Schmidt, Morten
    [J]. HEART, 2016, 102 (23) : 1883 - U111
  • [2] Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update
    An, Sang Joon
    Kim, Tae Jung
    Yoon, Byung-Woo
    [J]. JOURNAL OF STROKE, 2017, 19 (01) : 3 - 10
  • [3] Intracerebral haemorrhage profiles are changing: results from the Dijon population-based study
    Bejot, Yannick
    Cordonnier, Charlotte
    Durier, Jerome
    Aboa-Eboule, Corine
    Rouaud, Olivier
    Giroud, Maurice
    [J]. BRAIN, 2013, 136 : 658 - 664
  • [4] Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Yusuf, Salim
    Eikelboom, John
    Oldgren, Jonas
    Parekh, Amit
    Pogue, Janice
    Reilly, Paul A.
    Themeles, Ellison
    Varrone, Jeanne
    Wang, Susan
    Alings, Marco
    Xavier, Denis
    Zhu, Jun
    Diaz, Rafael
    Lewis, Basil S.
    Darius, Harald
    Diener, Hans-Christoph
    Joyner, Campbell D.
    Wallentin, Lars
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) : 1139 - 1151
  • [5] Declining US stroke hospitalization since 1997: National hospital discharge survey, 1988-2004
    Fang, Jing
    Alderman, Michael H.
    Keenan, Nora L.
    Croft, Janet B.
    [J]. NEUROEPIDEMIOLOGY, 2007, 29 (3-4) : 243 - 249
  • [6] Major risk factors for intracerebral hemorrhage in the young are modifiable
    Feldmann, E
    Broderick, JP
    Kernan, WN
    Viscoli, CM
    Brass, LM
    Brott, T
    Morgenstern, LB
    Wilterdink, JL
    Horwitz, RI
    [J]. STROKE, 2005, 36 (09) : 1881 - 1885
  • [7] FOLK2: Population 1, POP
  • [8] Declining Rates of Fatal and Nonfatal Intracerebral Hemorrhage: Epidemiological Trends in Australia
    Gattellari, Melina
    Goumas, Chris
    Worthington, John
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (06):
  • [9] Edoxaban versus Warfarin in Patients with Atrial Fibrillation
    Giugliano, Robert P.
    Ruff, Christian T.
    Braunwald, Eugene
    Murphy, Sabina A.
    Wiviott, Stephen D.
    Halperin, Jonathan L.
    Waldo, Albert L.
    Ezekowitz, Michael D.
    Weitz, Jeffrey I.
    Spinar, Jindrich
    Ruzyllo, Witold
    Ruda, Mikhail
    Koretsune, Yukihiro
    Betcher, Joshua
    Shi, Minggao
    Grip, Laura T.
    Patel, Shirali P.
    Patel, Indravadan
    Hanyok, James J.
    Mercuri, Michele
    Vogelmann, O.
    Gonzalez, C.
    Ahuad Guerrero, R.
    Rodriguez, M.
    Albisu, J.
    Rosales, E.
    Allall, O.
    Reguero, M.
    Alvarez, C.
    Garcia, M.
    Ameriso, S.
    Ameriso, P.
    Amuchastegui, M.
    Caceres, M.
    Beloscar, J.
    Petrucci, J.
    Berli, M.
    Budassi, N.
    Valle, M.
    Bustamante Labarta, G.
    Saravia, M.
    Caccavo, A.
    Fracaro, V.
    Cartasegna, L.
    Novas, V.
    Caruso, O.
    Saa Zarandon, R.
    Colombo, H.
    Morandini, M.
    Cuello, J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (22) : 2093 - 2104
  • [10] Apixaban versus Warfarin in Patients with Atrial Fibrillation
    Granger, Christopher B.
    Alexander, John H.
    McMurray, John J. V.
    Lopes, Renato D.
    Hylek, Elaine M.
    Hanna, Michael
    Al-Khalidi, Hussein R.
    Ansell, Jack
    Atar, Dan
    Avezum, Alvaro
    Cecilia Bahit, M.
    Diaz, Rafael
    Easton, J. Donald
    Ezekowitz, Justin A.
    Flaker, Greg
    Garcia, David
    Geraldes, Margarida
    Gersh, Bernard J.
    Golitsyn, Sergey
    Goto, Shinya
    Hermosillo, Antonio G.
    Hohnloser, Stefan H.
    Horowitz, John
    Mohan, Puneet
    Jansky, Petr
    Lewis, Basil S.
    Luis Lopez-Sendon, Jose
    Pais, Prem
    Parkhomenko, Alexander
    Verheugt, Freek W. A.
    Zhu, Jun
    Wallentin, Lars
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11) : 981 - 992